Association between Dyslipidemia Patterns and Early Cardiovascular Complications among Adults. A Cross-Sectional Clinical Study
DOI:
https://doi.org/10.53350/pjmhs020251911.5Keywords:
Dyslipidemia, LDL, HDL, triglycerides, cardiovascular complications, atherosclerosis, CIMT.Abstract
Background: Dyslipidemia is a significant risk factor that is not only majorly modifiable but also a cardiovascular disease (CVD) risk factor in South Asian populations due to the tendency to develop atherogenic lipid patterns at a younger age. Cardiovascular complications such as diastolic dysfunction, carotid intima-media thickness (CIMT) increase, subclinical ischemia and early ventricular remodeling usually proceed undetected. To enhance preventive cardiology, it is important to understand the association between the various patterns of dyslipidemia and early cardiac abnormalities.
Objectives: to establish the correlation between dyslipidemia trends and early heart diseases in adults.
Methods: A cross-sectional study was carried out on 100 adults aged 30-70 years, in terms of clinical data. After an overnight fast, detailed lipid profiles (TC, LDL-C, HDL-C, TG) were determined. The patterns of dyslipidemia were divided into isolated elevated LDL-C, isolated hypertriglyceridemia, low HDL-C and mixed dyslipidemia. Each participant had ECG and echocardiography to determine the early cardiovascular involvement, such as the diastolic dysfunction, enlargement of the CIMT, LV hypertrophy, decreased EF, and silent ischemic alterations. The SPSS 26 version was used to analyses the data, and Chi-square and logistic regression were used to evaluate the associations.
Results: Dyslipidemia was found in 72 percent of the participants and early cardiovascular problems were detected in 38 percent. Mixed dyslipidemia presented the most significant correlation (64.7%), then isolated high LDL-C (40.9%), and low HDL-C (33.3%). Early cardiac abnormalities were observed in only 10.7% of people having normal lipid profiles.
Conclusion: Mixed dyslipidemia and high LDL-C are channels with high predictivity of early cardiovascular complications. Lipid profiling must be regularly incorporated into cardiovascular risk measurement to help identify the problem early and provide preventive care on time.
References
Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Eur Heart J. 2017;38(32):2459–72. doi:10.1093/eurheartj/ehx144
Toth PP, Fazio S, Wong ND, Hull M, Nichols GA. Risk of cardiovascular events by LDL-C levels and statin use. J Clin Lipidol. 2018;12(6):1584–93. doi:10.1016/j.jacl.2018.09.009
Virani SS, Morris PB, Agarwala A, et al. ACC Expert Consensus Decision Pathway on the management of atherosclerotic risk. J Am Coll Cardiol. 2021;77(5):538–621. doi:10.1016/j.jacc.2020.11.055
Joshi PH, Khokhar AA, Massaro JM, et al. Remnant lipoprotein cholesterol and cardiovascular events. Atherosclerosis. 2016;252:215–22. doi:10.1016/j.atherosclerosis.2016.07.922
Navar AM, Peterson ED, Li S, et al. Association of LDL-C with cardiovascular outcomes. Circulation. 2016;133(21):2104–12. doi:10.1161/CIRCULATIONAHA.115.018380
Zhao W, Hasegawa K, Chen M. Lipid profile abnormalities and early CVD in Asian populations. Int J Cardiol. 2017;230:214–20. doi:10.1016/j.ijcard.2016.12.119
Castelli WP. HDL and coronary heart disease risk. Am J Cardiol. 2018;122(3):410–6. doi:10.1016/j.amjcard.2018.04.021
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guidelines for CVD prevention. Circulation. 2019;140(11):e596–646. doi:10.1161/CIR.0000000000000678
Hussain A, Ali I, Ahmed K, et al. Prevalence of dyslipidemia and associated factors in Pakistan. J Pak Med Assoc. 2021;71(9):2203–8. doi:10.47391/JPMA.1270
Rana JS, Tabada GH, Solomon MD, et al. HDL cholesterol and heart disease risk. J Am Heart Assoc. 2016;5(6):e003509. doi:10.1161/JAHA.116.003509
Lorenz MW, Markus HS, Bots ML, et al. Carotid intima–media thickness for cardiovascular risk prediction. Lancet. 2016;387(10013):1799–807. doi:10.1016/S0140-6736(15)60569-0
White J, Sofat R, Hemani G, et al. LDL cholesterol and ischemic heart disease risk: Mendelian randomization. BMJ. 2016;352:i496. doi:10.1136/bmj.i496
Nicholls SJ, Nelson AJ. Triglycerides and atherosclerotic cardiovascular risk. Curr Opin Cardiol. 2019;34(4):350–5. doi:10.1097/HCO.0000000000000633
Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors and cardiovascular disease in LMICs. N Engl J Med. 2020;382(9):779–89. doi:10.1056/NEJMoa1901455
Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for dyslipidemia. J Clin Lipidol. 2015;9(2):129–69. doi:10.1016/j.jacl.2015.02.003
Lin SX, Wang L, Pan J, et al. Dyslipidemia and early subclinical atherosclerosis in adults. Lipids Health Dis. 2018;17(1):165. doi:10.1186/s12944-018-0811-1
Siddiqui M, Shoaib M, Raza S, et al. Lipid profile patterns and CVD risk in South Asians. Pak Heart J. 2022;55(3):232–8. doi:10.47144/phj.v55i3.232
Ji X, Zhao Y, Pan X, et al. LDL-C/HDL-C ratio and early cardiovascular dysfunction. Clin Chim Acta. 2021;522:132–8. doi:10.1016/j.cca.2021.08.018
Stone NJ, Robinson JG, Lichtenstein AH, et al. Treatment of blood cholesterol for ASCVD prevention. Circulation. 2019;139(25):e1082–143. doi:10.1161/CIR.0000000000000625
Saeed A, Virani SS, Mulukutla SR, et al. Lipoprotein(a), dyslipidemia, and subclinical coronary atherosclerosis. Am J Cardiol. 2020;125(5):715–21. doi:10.1016/j.amjcard.2019.11.039
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2025 ATTAULLAH KHAN NIAZI, MUHAMMAD UMAR ABBAS, AIMEN ABBAS, MUHAMMAD SHAHZAIB SAJJAD, ANEELA JUMADIN, HARIS ABDULLAH
This work is licensed under a Creative Commons Attribution 4.0 International License.
